Date of event has been estimated.The unique device identifier (udi) is unknown because the part and lot number were not provided date of implant has been estimated.The device was not returned for evaluation.A review of the lot history record and complaint history of the reported lot could not be conducted because the part and lot numbers were not provided.The investigation was unable to determine a conclusive cause for the reported wall apposition; however, factors that may contribute to wall apposition include, but are not limited to, incorrect device size for lesion, patient anatomical morphology, and patient disease state.There is no indication of a product quality issue with respect to manufacture, design or labeling.The adverse events referenced in are being filed under a separate medwatch report number.Attachment article, titled "comparison of 6-month vascular healing response after bioresorbable polymer versus durable polymer drug-eluting stent implantation in patients with acute coronary syndromes: a randomized serial optical coherence tomography study.".
|
It was reported through a research article identifying xience alpine drug eluting stents (des) that were related to the following outcomes: malapposed struts, target lesion revascularization and in-stent restenosis.Specific patient information is documented as unknown.Details are listed in the attached article, titled "comparison of 6-month vascular healing response after bioresorbable polymer versus durable polymer drug-eluting stent implantation in patients with acute coronary syndromes: a randomized serial optical coherence tomography study.".
|